Antibacterial medical isolation gown and manufacturing method thereof

A technology of isolation gown and antibacterial film, which is applied in the field of medical equipment and can solve the problems of reduced antibacterial effect

Pending Publication Date: 2021-05-11
无锡市圣华盾医疗科技有限公司
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, many antibacterial non-woven fabrics are coated with antibacterial agents on the non-woven fabric layer, and then form an antibacterial protective barrier on the surface of th...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibacterial medical isolation gown and manufacturing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] The present invention is an antibacterial medical isolation gown, comprising at least one outer non-woven fabric layer, a melt-blown nanofiltration layer and at least one inner non-woven fabric layer sequentially arranged from outside to inside, the outer non-woven fabric layer The cloth layer and the inner non-woven fabric layer comprise the following raw materials in parts by weight: 95 parts of polypropylene (PP), 15 parts of metallocene polypropylene (LMPP), 15 parts of maleic acid grafted LMPP, 8 parts of polylysine The molecular weight of the polylysine is 3000-4000, 2 parts of sodium benzoate, 3 parts of hyaluronic acid with a molecular weight of 1 million, 1 part of antioxidant, 1 part of nucleating agent, and 0.5 part of calcium stearate.

[0021] The antioxidant is a phosphite antioxidant.

[0022] The nucleating agent is an organic phosphate nucleating agent, NA-21.

[0023] The manufacture method of above-mentioned antibacterial medical isolation clothing, ...

Embodiment 2

[0028] The difference between Example 2 and Example 1 is that the outer nonwoven layer and the inner nonwoven layer contain the following raw materials in parts by weight: 90 parts of polypropylene (PP), 10 parts of metallocene polypropylene (LMPP) , 10 parts of maleic acid grafted LMPP, 5 parts of polylysine, 1 part of zinc oxide, 1 part of hyaluronic acid, 0.1 part of antioxidant, 0.1 part of nucleating agent, 0.1 part of calcium stearate.

Embodiment 3

[0030] The difference between Example 3 and Example 1 is that the outer nonwoven layer and the inner nonwoven layer contain the following raw materials in parts by weight: 100 parts of polypropylene (PP), 20 parts of metallocene polypropylene (LMPP) , 20 parts of maleic acid grafted LMPP, 10 parts of polylysine, 3 parts of silver ion antibacterial agent, 5 parts of hyaluronic acid, 2 parts of antioxidant, 2 parts of nucleating agent, 1 part of calcium stearate .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an antibacterial medical isolation gown which comprises at least one outer non-woven fabric layer, a melt-blown nano-filtration layer and at least one inner non-woven fabric layer which are sequentially arranged from outside to inside, and the outer non-woven fabric layer and the inner non-woven fabric layer comprise the following raw materials in parts by weight: 90-100 parts of polypropylene (PP), 10-20 parts of metallocene polypropylene (LMPP), 10 to 20 parts of maleic anhydride grafted LMPP, 5 to 10 parts of polylysine, 1 to 3 parts of antibacterial agent, 1 to 5 parts of softening agent, 0.1 to 2 parts of antioxidant, 0.1 to 2 parts of nucleating agent and 0.1 to 1 part of lubricating agent. The invention further discloses a manufacturing method of the antibacterial medical isolation gown. The antibacterial medical isolation gown has the advantages of being light, soft, comfortable to wear and lasting in antibacterial effect. According to the manufacturing method of the antibacterial medical isolation gown, the raw materials are sequentially added into a mixer to be mixed according to the sequence, and the situation that due to the fact that all the raw materials are added at a time according to the weight parts, the raw materials are not fully mixed and melted, and the product quality is reduced is reduced.

Description

technical field [0001] The invention relates to the technical field of medical appliances, in particular to an antibacterial medical isolation garment. Background technique [0002] Medical isolation gowns refer to protective clothing used by medical personnel and people entering specific medical and health areas, which can effectively resist the penetration of blood, harmful ultrafine dust, and germs, or protective equipment used to protect patients from infection. Nosocomial infection is one of the most important two-way isolation measures to prevent patients from being infected. [0003] The current medical isolation gown is generally of SSMMS structure, with two layers of non-woven fabric on the outside, two melt-blown filter layers in the middle, and one layer of non-woven fabric on the inside. The outer S layer is generally made of non-woven fabric with waterproof treatment. Since the non-woven materials used in medical isolation gowns are often in direct contact with...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A41D13/12A41D31/30D01F8/06D01F1/10D06M17/00D04H3/147D06N3/00D06N3/12
CPCA41D13/12A41D31/30D01F8/06D01F1/10D01F1/103D06M17/00D04H3/147D06N3/12D06N3/0011
Inventor 李娟
Owner 无锡市圣华盾医疗科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products